Shubhankar Nath
  • Senior Oncology Scientist, Bioink and Tissue Engineering, Cellink LLC
Research focus
  • Cancer biology
  • 1 Author merit

Education

Ph.D., The University of Texas at Austin, USA

Publications

• Nath et al., 2016. Dynein separately partners with NDE1 and dynactin to orchestrate T cell focused secretion. The Journal of Immunology. 197: 2090-2101.
• Nath et al., 2010. Potential for Largemouth bass virus to associate within and gain protection from bacterial biofilms. Journal of Aquatic Animal Health. 22: 95-101.
• Rizvi, I., Nath., S., et al., 2018. A combination of Visudyne and a lipid-anchored liposomal formulation of benzoporphyrin derivative enhances photodynamic therapy efficacy in a 3D model for ovarian cancer. Accepted. Photochemistry & Photobiology.
• Afshar, S., Nath, S., et al., 2018. Identification of hydrodynamic forces around 3D surrogates using particle image velocimetry in a microfluidic channel. SPIE Conference Proceedings. Vol. 10491.
1 Protocol published
Photodynamic Therapy in a 3D Model of Ovarian Cancer
Authors:  Shubhankar Nath and Kaitlin Moore, date: 08/05/2019, view: 268, Q&A: 0
Photodynamic therapy (PDT), is a clinically-approved light-based anti-cancer treatment modality in which a photoactivatable photosensitizer is irradiated with an appropriate wavelength of light to generate cytotoxic molecules to kill cancer cells. ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.